Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Primary Progressive Aphasia
NCT06066710Phase 1Recruiting
- Sponsor
- University of Missouri
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in primary progressive aphasia (PPA) comparing Propanolol and MRI with Placebo and MRI (2 arms). Primary endpoint: Neuropsychological Assessment Battery Naming at 18 weeks. Started Jan 2025; status: recruiting.
02
Drugs
propranolol
03
Conditions
primary progressive aphasia (PPA)
Beyond the preview
Go deeper on NCT06066710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06066710.